- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 94M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $5.99B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.61B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.53B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $283M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.13B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.09B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $8.85B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $7.43B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.08B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $860M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $21.4B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $20.29B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 93.5M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $64M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $78M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $13.98B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $14.06B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.75 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.75 |
| Net Income | Q1 2025 · Mar 31, 2024 | $70M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$21M |
| Revenue | Q1 2025 · Mar 31, 2024 | $257M |